Skip to main content

Norbert Pardi

NIH Rank #976
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Translational
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11396783Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pharmacology
  • Microbiology & Immunology

NIH Funding · FY2025

Linked Award Amount
$6.3M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#976
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Norbert Pardi. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Norbert Pardi as a PI. Multi-PI records show the full award amount for context.

  • 1U01CA305709-01U01
    Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection
    $4.9M
    award amount
  • 2R01AI153064-05A1R01
    Lipid nanoparticle adjuvants for mRNA vaccines: composition-function relation and mechanism of action
    $803.5K
    award amount
  • 5R01CA283736-02R01
    Innovative mRNA vaccines to enhance the efficacy of T-cell transfer therapies against solid tumors
    $614.1K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Norbert Pardi as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, Los Angeles
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1554
  6. 2024
    Entered Top 25% Nationally
    Ranked #1554
  7. 2024
    Entered Top 10% Nationally
    Ranked #1554
  8. 2025
    $5M Cumulative Funding
  9. 2025
    $10M Cumulative Funding
  10. 2025
    Entered Top 5% Nationally
    Ranked #976
  11. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  12. 2025
    R01 Grant Holder
  13. 2025
    Program/Center Grant Leader
Norbert Pardi | NIH Award Records | ConductScience